Trial Profile
Clinical study to evaluate efficacy and safety of combination therapy with mitiglinide and voglibose in patients with type 2 diabetes mellitus whose glucose control is inadequate with voglibose alone.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jul 2011
Price :
$35
*
At a glance
- Drugs Mitiglinide/voglibose (Primary) ; Voglibose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 21 Jul 2011 New trial record